Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
CCRN vs AMN vs TBI vs HCSG vs MAN
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Staffing & Employment Services
Medical - Care Facilities
Staffing & Employment Services
CCRN vs AMN vs TBI vs HCSG vs MAN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Staffing & Employment Services | Medical - Care Facilities | Staffing & Employment Services |
| Market Cap | $423M | $869M | $182M | $1.60B | $1.41B |
| Revenue (TTM) | $761M | $3.42B | $1.25B | $1.84B | $17.96B |
| Net Income (TTM) | $-99M | $-32M | $-53M | $59M | $-13M |
| Gross Margin | 18.2% | 25.5% | 28.4% | 13.3% | 16.7% |
| Operating Margin | -0.9% | 0.3% | -2.6% | 3.0% | 0.8% |
| Forward P/E | 133.8x | 11.0x | — | 20.8x | 8.3x |
| Total Debt | $2M | $803M | $171M | $25M | $2.39B |
| Cash & Equiv. | $109M | $34M | $25M | $161M | $871M |
CCRN vs AMN vs TBI vs HCSG vs MAN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cross Country Healt… (CCRN) | 100 | 215.7 | +115.7% |
| AMN Healthcare Serv… (AMN) | 100 | 50.7 | -49.3% |
| TrueBlue, Inc. (TBI) | 100 | 38.9 | -61.1% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| ManpowerGroup Inc. (MAN) | 100 | 44.0 | -56.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCRN vs AMN vs TBI vs HCSG vs MAN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CCRN ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.78
- -10.5% 10Y total return vs HCSG's -26.8%
- Lower volatility, beta 0.78, Low D/E 0.7%, current ratio 3.78x
- Beta 0.78, current ratio 3.78x
AMN lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, TBI doesn't own a clear edge in any measured category.
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs CCRN's -21.6%
- 3.2% margin vs CCRN's -13.0%
- +55.8% vs MAN's -17.0%
MAN is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (8.3x vs 20.8x)
- 4.7% yield; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs CCRN's -21.6% | |
| Value | Lower P/E (8.3x vs 20.8x) | |
| Quality / Margins | 3.2% margin vs CCRN's -13.0% | |
| Stability / Safety | Beta 0.78 vs TBI's 1.13, lower leverage | |
| Dividends | 4.7% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +55.8% vs MAN's -17.0% | |
| Efficiency (ROA) | 7.3% ROA vs CCRN's -19.8%, ROIC 9.0% vs -0.9% |
CCRN vs AMN vs TBI vs HCSG vs MAN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CCRN vs AMN vs TBI vs HCSG vs MAN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCSG leads in 3 of 6 categories
AMN leads 1 • MAN leads 1 • CCRN leads 0 • TBI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MAN is the larger business by revenue, generating $18.0B annually — 23.6x CCRN's $761M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to CCRN's -13.0%. On growth, AMN holds the edge at +99.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $761M | $3.4B | $1.2B | $1.8B | $18.0B |
| EBITDAEarnings before interest/tax | $9M | $127M | -$10M | $72M | $236M |
| Net IncomeAfter-tax profit | -$99M | -$32M | -$53M | $59M | -$13M |
| Free Cash FlowCash after capex | $41M | $714M | -$60M | $139M | -$161M |
| Gross MarginGross profit ÷ Revenue | +18.2% | +25.5% | +28.4% | +13.3% | +16.7% |
| Operating MarginEBIT ÷ Revenue | -0.9% | +0.3% | -2.6% | +3.0% | +0.8% |
| Net MarginNet income ÷ Revenue | -13.0% | -0.9% | -4.3% | +3.2% | -0.1% |
| FCF MarginFCF ÷ Revenue | +5.4% | +20.9% | -4.8% | +7.6% | -0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +99.9% | -100.0% | +6.6% | +7.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.0% | +56.8% | -37.5% | +175.0% | +36.2% |
Valuation Metrics
MAN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, AMN's 8.6x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $423M | $869M | $182M | $1.6B | $1.4B |
| Enterprise ValueMkt cap + debt − cash | $317M | $1.6B | $329M | $1.5B | $2.9B |
| Trailing P/EPrice ÷ TTM EPS | -4.47x | -9.06x | -3.73x | 27.54x | -104.90x |
| Forward P/EPrice ÷ next-FY EPS est. | 133.84x | 11.05x | — | 20.83x | 8.28x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 23.75x | 8.63x | 160.03x | 22.38x | 9.02x |
| Price / SalesMarket cap ÷ Revenue | 0.40x | 0.32x | 0.11x | 0.87x | 0.08x |
| Price / BookPrice ÷ Book value/share | 1.31x | 1.35x | 0.65x | 3.19x | 0.69x |
| Price / FCFMarket cap ÷ FCF | 10.55x | 3.72x | — | 11.49x | — |
Profitability & Efficiency
HCSG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-27 for CCRN. CCRN carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMN's 1.25x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs MAN's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -27.1% | -5.0% | -18.7% | +11.8% | -0.6% |
| ROA (TTM)Return on assets | -19.8% | -1.4% | -8.1% | +7.3% | -0.1% |
| ROICReturn on invested capital | -0.9% | +1.6% | -5.2% | +9.0% | +5.6% |
| ROCEReturn on capital employed | -0.8% | +2.0% | -5.3% | +7.7% | +6.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 4 | 7 | 1 |
| Debt / EquityFinancial leverage | 0.01x | 1.25x | 0.62x | 0.05x | 1.16x |
| Net DebtTotal debt minus cash | -$106M | $769M | $146M | -$136M | $1.5B |
| Cash & Equiv.Liquid assets | $109M | $34M | $25M | $161M | $871M |
| Total DebtShort + long-term debt | $2M | $803M | $171M | $25M | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | -1.39x | -1.70x | -46.19x | 33.02x | 1.98x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,888 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, HCSG leads with a +55.8% total return vs MAN's -17.0%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs AMN's -37.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +62.4% | +48.7% | +36.6% | +28.6% | +1.2% |
| 1-Year ReturnPast 12 months | -5.4% | +14.6% | +51.0% | +55.8% | -17.0% |
| 3-Year ReturnCumulative with dividends | -44.3% | -75.1% | -60.2% | +48.6% | -46.4% |
| 5-Year ReturnCumulative with dividends | -22.5% | -75.1% | -78.7% | -21.1% | -64.9% |
| 10-Year ReturnCumulative with dividends | -10.5% | -41.5% | -68.4% | -26.8% | -30.8% |
| CAGR (3Y)Annualised 3-year return | -17.7% | -37.1% | -26.4% | +14.1% | -18.8% |
Risk & Volatility
Evenly matched — CCRN and AMN each lead in 1 of 2 comparable metrics.
Risk & Volatility
CCRN is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMN currently trades 94.7% from its 52-week high vs MAN's 64.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 1.08x | 1.13x | 1.12x | 1.03x |
| 52-Week HighHighest price in past year | $14.99 | $23.74 | $7.78 | $24.39 | $47.34 |
| 52-Week LowLowest price in past year | $7.43 | $14.87 | $3.18 | $12.66 | $25.15 |
| % of 52W HighCurrent price vs 52-week peak | +87.3% | +94.7% | +77.2% | +91.5% | +64.3% |
| RSI (14)Momentum oscillator 0–100 | 53.1 | 57.2 | 83.2 | 61.8 | 47.1 |
| Avg Volume (50D)Average daily shares traded | 552K | 849K | 386K | 676K | 1.1M |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CCRN as "Hold", AMN as "Buy", TBI as "Buy", HCSG as "Hold", MAN as "Hold". Consensus price targets imply 24.5% upside for MAN (target: $38) vs -18.9% for CCRN (target: $11). MAN is the only dividend payer here at 4.71% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $10.61 | $22.50 | $5.75 | $24.50 | $37.86 |
| # AnalystsCovering analysts | 14 | 17 | 10 | 15 | 29 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +4.7% |
| Dividend StreakConsecutive years of raises | 1 | — | 0 | 20 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — | $1.43 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +0.2% | +0.6% | +3.9% | +2.7% |
HCSG leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). AMN leads in 1 (Income & Cash Flow). 1 tied.
CCRN vs AMN vs TBI vs HCSG vs MAN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CCRN or AMN or TBI or HCSG or MAN a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate AMN Healthcare Services, Inc. (AMN) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCRN or AMN or TBI or HCSG or MAN?
On forward P/E, ManpowerGroup Inc.
is actually cheaper at 8. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CCRN or AMN or TBI or HCSG or MAN?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 1%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: CCRN returned -10. 5% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCRN or AMN or TBI or HCSG or MAN?
By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.
(CCRN) is the lower-risk stock at 0. 78β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 46% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 125% for AMN Healthcare Services, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CCRN or AMN or TBI or HCSG or MAN?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCRN or AMN or TBI or HCSG or MAN?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus -1. 7% for TBI. At the gross margin level — before operating expenses — AMN leads at 22. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCRN or AMN or TBI or HCSG or MAN more undervalued right now?
On forward earnings alone, ManpowerGroup Inc.
(MAN) trades at 8. 3x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 125. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MAN: 24. 5% to $37. 86.
08Which pays a better dividend — CCRN or AMN or TBI or HCSG or MAN?
In this comparison, MAN (4.
7% yield) pays a dividend. CCRN, AMN, TBI, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is CCRN or AMN or TBI or HCSG or MAN better for a retirement portfolio?
For long-horizon retirement investors, ManpowerGroup Inc.
(MAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 03), 4. 7% yield). Both have compounded well over 10 years (MAN: -30. 8%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCRN and AMN and TBI and HCSG and MAN?
These companies operate in different sectors (CCRN (Healthcare) and AMN (Healthcare) and TBI (Industrials) and HCSG (Healthcare) and MAN (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CCRN is a small-cap quality compounder stock; AMN is a small-cap quality compounder stock; TBI is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; MAN is a small-cap income-oriented stock. MAN pays a dividend while CCRN, AMN, TBI, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.